This Key Event Relationship is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Relationship: 2942
Title
Activation of MEK, ERK1/2 leads to Increase, intracellular calcium
Upstream event
Downstream event
Key Event Relationship Overview
AOPs Referencing Relationship
AOP Name | Adjacency | Weight of Evidence | Quantitative Understanding | Point of Contact | Author Status | OECD Status |
---|---|---|---|---|---|---|
Activation of MEK-ERK1/2 leads to deficits in learning and cognition via disrupted neurotransmitter release | adjacent | Moderate | Travis Karschnik (send email) | Under development: Not open for comment. Do not cite | ||
Activation of MEK-ERK1/2 leads to deficits in learning and cognition via ROS and apoptosis | adjacent | Moderate | Travis Karschnik (send email) | Under development: Not open for comment. Do not cite |
Taxonomic Applicability
Sex Applicability
Sex | Evidence |
---|---|
Female | Moderate |
Mixed | Moderate |
Life Stage Applicability
Term | Evidence |
---|---|
Birth to < 1 month | Moderate |
1 to < 3 months | Moderate |
Pregnancy | Moderate |
Key Event Relationship Description
Astrocytes are networked together by a series of gap junctions permitting to propagate Ca2+ waves through the linked network (Lobsiger and Cleveland 2007), and Ca2+-mediated intercellular communication is a mechanism by which astrocytes communicate with each other and modulate the activity of adjacent cells (Verderio et al., 2001). Metal mixture (MM) induced alteration in astrocyte morphology may influence [Ca2+]i (Barres et al., 1989); in contrast, an increase in [Ca2+]i may also play a key role in altering astrocyte cytoskeleton, affecting the glia-neuron interaction (Shelton et al., 2000).
Inhibition of GFAP immunoreactivity by MM in developing brain appears to be caused by astrocyte apoptosis. In primary cultures of astrocytes, our data show that MM synergistically induced apoptosis (Rai and others 2010). This was manifested by the activation of MEK/ERK, followed by the activation of JNK pathways, which then enhanced intracellular Ca2+ levels and subsequently ROS generation.
Evidence Collection Strategy
This KER was identified as part of an Environmental Protection Agency effort to represent putative AOPs from peer-reviewed literature which were heretofore unrepresented in the AOP-Wiki. The KER is referenced in publications which were cited in the originating work for the putative AOP "Activation of MEK-ERK1/2 leads to deficits in learning and cognition via ROS and apoptosis", Katherine von Stackelberg & Elizabeth Guzy & Tian Chu & Birgit Claus Henn, 2015. Exposure to Mixtures of Metals and Neurodevelopmental Outcomes: A Multidisciplinary Review Using an Adverse Outcome Pathway Framework, Risk Analysis, John Wiley & Sons, vol. 35(6), pages 971-1016, June.
This evidence was assembled from a literature search relying on standard search engines such as PubMed, Web of Science, Google Scholar, Environmental Index, Scopus, Toxline, and Toxnet and the search strategy included terms related to metal mixtures, individual metals (e.g., arsenic, lead, manganese, and cadmium), neurodevelopmental health outcomes, and associated Medical Subject Headings (MeSH) terms.
Evidence Supporting this KER
Biological Plausibility
Empirical Evidence
We treated the astrocytes with a metal-mixture (MM) of arsenic, cadmium, and lead and observed that the MM triggered [Ca2+]i release (Rai and others 2010). The [Ca2+]i release reached its peak after 30 min of MM treatment. Similarly, MM triggered ROS generation, and the ROS generation reached its peak after 1 h of MM treatment. To investigate whether the [Ca2+]i release was ROS, ERK1/2, or JNK1/2 –dependent, we incubated the MM-treated astrocytes with an antioxidant (a-tocopherol, 200 lg/ml), PD98059 (10lM), or SP600125 (10lM). a-Tocopherol itself was nontoxic. We observed that PD98059 (10lM) or SP600125 (10lM) suppressed [Ca2+]i release, but a-tocopherol (200 lg/ml) did not. This suggested that [Ca2+]i release in MM-treated astrocytes was ERK1/2 and JNK1/2 dependent (Rai and others 2010).
Yael and Breitbart (2015) demonstrated for the first time that mouse sperm ERK1/2 is activated upon ZP addition, and that ERK1/2 mediates the elevation of intracellular Ca2+ in the sperm cell prior to the occurrence of the acrosome reaction. The fact that the acrosome reaction, induced by the Ca2+-ionophore A23187, was not inhibited by U0126 suggests that ERK1/2 mediates the acrosome reaction by activating Ca2+ transport into the cell. Direct determination of intracellular [Ca2+] revealed that Ca2+ influx induced by EGF or ZP was completely blocked by U0126. Thus, it has been established that the increase in ERK1/2 phosphorylation/activation in response to ZP or by activation of the EGF receptor (EGFR) by EGF, is a key event for intracellular Ca2+ elevation and the subsequent occurrence of the acrosome reaction (Jaldety et al., 2015).
To examine the relationship between Ca2+ and Erk1/2 signaling, Levin and Borodinsky (2022) inhibited Mek1/2 with PD0325901 and found that this prevents the injury-induced increase in Ca2+ activity in cells lateral to the axial musculature across the entire 800 µm-wide region measured. This suggests that injury-induced Erk1/2 activation recruits Ca2+ activity to promote regeneration of the larval tail. Consistent with recruitment of Ca2+ activity across a wide region of tail, activated Erk1/2 is also present in at least the posterior 800 µm of stump (Levin et al., 2022). However, unlike Ca2+ activity, Erk1/2 signaling at 20 mpa is activated in a gradient. This could mean that even the lowest level of Erk1/2 signal measured in 800 µm of amputated tail is sufficient to induce the Ca2+ response, or that a signal is propagated anteriorly from the cells adjacent to the amputation where injury induces high Erk1/2 activation (Levin et al., 2022).
Uncertainties and Inconsistencies
Known modulating factors
Quantitative Understanding of the Linkage
Response-response Relationship
Time-scale
Exposures were conducted for 2 min, 5 min, 10 min, 30 min, 1 h, 2 h, and 24 h. The [Ca2+]i release reached its peak after 30 min of MM treatment (Rai and others 2010).
Known Feedforward/Feedback loops influencing this KER
The activity of many protein kinases is modulated by Ca2+ and/or Ca2+/calmodulin either directly (PKC, CaM kinase II) or indirectly (PKA via stimulation of adenylyl cyclase and phosphodiesterase by Ca2+/calmodulin) (Kern et al., 1995). Therefore, the effects of Ca2+ and protein kinases on cytoskeletal proteins and neurite initiation are likely to be mediated, at least in part, by changes in protein phosphorylation (Kern et al., 1995).
Domain of Applicability
References
Asit Rai and others, Characterization of Developmental Neurotoxicity of As, Cd, and Pb Mixture: Synergistic Action of Metal Mixture in Glial and Neuronal Functions, Toxicological Sciences, Volume 118, Issue 2, December 2010, Pages 586–601, https://doi.org/10.1093/toxsci/kfq266
Barres, B. A., L. L. Chun, and Corey. "Calcium current in cortical astrocytes: induction by cAMP and neurotransmitters and permissive effect of serum factors." Journal of Neuroscience 9.9 (1989): 3169-3175.
Jaldety, Yael, and Haim Breitbart. "ERK1/2 mediates sperm acrosome reaction through elevation of intracellular calcium concentration." Zygote 23.5 (2015): 652-661.
Kern, Marcey, and Gerald Audesirk. "Inorganic lead may inhibit neurite development in cultured rat hippocampal neurons through hyperphosphorylation." Toxicology and applied pharmacology 134.1 (1995): 111-123.
Levin, Jacqueline B., and Laura N. Borodinsky. "Injury-induced Erk1/2 signaling tissue-specifically interacts with Ca2+ activity and is necessary for regeneration of spinal cord and skeletal muscle." Cell calcium 102 (2022): 102540.
Lobsiger, C. S., and Cleveland, D. W. (2007). Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat. Neuro-sci. 10, 1355–1360.
Shelton, Marilee K., and Ken D. McCarthy. "Hippocampal astrocytes exhibit Ca2+‐elevating muscarinic cholinergic and histaminergic receptors in situ." Journal of neurochemistry 74.2 (2000): 555-563.
Verderio, Claudia, and Michela Matteoli. "ATP mediates calcium signaling between astrocytes and microglial cells: modulation by IFN-γ." The Journal of Immunology 166.10 (2001): 6383-6391.